poisar

Stocks · News reference

Citigroup Maintains Bullish Rating on Arrowhead Pharmaceuticals

Fiscal.ai

Citigroup analyst Eric Joseph has reaffirmed a bullish rating and a $105 price target for Arrowhead Pharmaceuticals (ARWR).

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading